openPR Logo
Press release

Head and Neck Cancer Market Key Players Analysis - Advaxis, Inc. (US), Amgen, Inc. (US), AstraZeneca plc (UK), Boehringer Ingelheim GmbH (Germany).

02-27-2025 08:28 AM CET | Health & Medicine

Press release from: Insightace Analytic Pvt Ltd.

Head and Neck Cancer Market

Head and Neck Cancer Market

InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Head and Neck Cancer Market- by Products (Cytotoxic Agents, Antimetabolites, Abitrexate/Mexate/Folex (methotrexate), Hydrea (hydroxyurea), Antitubulins, Taxotere (docetaxel), Others (Platinum Agents, Fluoropyrimidines), Platinol (cisplatin), 5-fluorouracil (5-FU), EGFR Inhibitors (mAbs), Erbitux (cetuximab), Vectibix (panitumumab), Theracim/Theraloc (nimotuzumab), EGFR Inhibitors (TKIs), Tarceva (erlotinib), Iressa (gefitinib), Tykerb/Tyverb (lapatinib), PD1 Inhibitors, Keytruda (pembrolizumab), Opdivo (nivolumab), Pipeline Drugs (Late-stage), EGFR Inhibitors (mAbs), Vectibix (panitumumab), PDL1 Inhibitors, Imfinzi (durvalumab), Bavencio (avelumab), CTLA4 Inhibitors, Yervoy (ipilimumab) and Tremelimumab), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1217

According to the latest research by InsightAce Analytic, the global Head and Neck Cancer market is valued at US$ 2.44 Billion in 2021, and it is expected to reach US$ 9.07 Billion by 2030, with a CAGR of 16.2% during a forecast period of 2022-2030.

Head and neck cancer is caused mainly by squamous cells, which line the mucosal surfaces of the head and neck, including the interior of the mouth, nose, and throat. Head and neck cancers can affect the salivary glands, pharynx, larynx, paranasal sinuses, nasal cavity, and oral cavity. There are approximately 630,000 new cases of head and neck cancer (HNC) each year, making it the sixth most common cancer globally. Squamous cell carcinomas, or HNCs, affect the salivary glands, oral cavity, scalp, and paranasal sinuses in addition to the nasal cavities and paranasal sinuses. The mouth cavity is where cancer most frequently develops and is largely connected with cigarette and alcohol usage.

The main factor driving the head and neck cancer market is the rise in head and neck malignancies. The aging population, substantial financing for oncology research, unmet medical needs, growing market rivalry, improved regulatory framework, the aging population, and rising government support are a few additional factors driving the growth of the global head and neck cancer market. The head and neck cancer sector nevertheless raises worries despite these reasons. The high cost of therapy may hamper market expansion, the drawbacks of present treatments, the lack of healthcare coverage, and the inadequate healthcare systems in low- and middle-income nations. The efficiency of medication development is predicted to rise as scientific and technological developments in R&D and manufacturing processes increase. However, a sizable proportion of clinical trials fall short of expectations. This is a significant barrier to the growth of new companies in the global market for head and neck cancer.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-02

North America is anticipated to be the major contributor to the Head and Neck Cancer market over the forecast years due to the rising incidence of head and neck cancer, rising use of cutting-edge medical technologies, large market player presence, high healthcare costs, and increased knowledge of contemporary cancer treatments. In addition, the Asia Pacific regional market is expected to register significant growth during the estimated period. The need for therapies for treating head and neck cancer is anticipated to increase due to the region's rapidly expanding patient population, which would likely propel the market. Manufacturers should benefit financially from expanding the biopharmaceutical sector and local government initiatives in the coming years.

Major market players operating in the Head and Neck Cancer market include
Advaxis, Inc. (US), Amgen, Inc. (US), AstraZeneca plc (UK), Boehringer Ingelheim GmbH (Germany), Bristol-Myers Squibb Company (Ono Pharmaceutical Co., Ltd.) (Japan), Cel-Sci Corporation (US), Five Prime Therapeutics, Inc. (US), GlaxoSmithKline plc (UK), Incyte Corporation (US), IRX Therapeutics, Inc. (US), MacroGenics, Inc. (US), Merck KGaA (Germany), Novartis AG (Switzerland), Pfizer, Inc., Roche Holdings AG (Genentech) (Switzerland), Viracta Therapeutics (US) among others.

Recent collaborations and agreements in the market:
• In July 2021, Novartis (Switzerland) partnered with Kura Oncology, Inc., a clinical-stage biopharmaceutical company, to assess the efficacy of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma.
• In June 2021, CEL-SCI Corporation (United States) revealed the results of a 9.5-year pivotal Phase 3 research for its immunotherapy Multikine (Leukocyte Interleukin, Injection) in the treatment of advanced (stages III and IV) primary (previously untreated) squamous cell carcinoma of the head and neck (SCCHN). In a significant head and neck cancer phase 3 study, CEL-Multikine® SCI's Immunotherapy achieved a 14.1% 5-year survival benefit (62.7% vs 48.6%) in the group undergoing surgery plus radiotherapy.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1217

Market Segments
Global Head and Neck Cancer Market, by Products, 2022-2030 (Value US$ Mn)
• Cytotoxic Agents
• Antimetabolites
• Abitrexate/ Mexate/ Folex (methotrexate)
• Hydrea (hydroxyurea)
• Antitubulins
• Taxotere (docetaxel)
• Others (Platinum Agents, Fluoropyrimidines)
• Platinol (cisplatin)
• 5-fluorouracil (5-FU)
• EGFR Inhibitors (mAbs)
• Erbitux (cetuximab)
• Vectibix (panitumumab)
• Theracim/Theraloc (nimotuzumab)
• EGFR Inhibitors (TKIs)
• Tarceva (erlotinib)
• Iressa (gefitinib)
• Tykerb/Tyverb (lapatinib)
• PD1 Inhibitors
• Keytruda (pembrolizumab)
• Opdivo (nivolumab)
• Pipeline Drugs (Late-stage)
• EGFR Inhibitors (mAbs)
• Vectibix (panitumumab)
• PDL1 Inhibitors
• Imfinzi (durvalumab)
• Bavencio (avelumab)
• CTLA4 Inhibitors
• Yervoy (ipilimumab)
• Tremelimumab
Global Head and Neck Cancer Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Head and Neck Cancer Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Head and Neck Cancer market
 To receive an industry overview and future trends of the Head and Neck Cancer market
 To analyze the Head and Neck Cancer market drivers and challenges
 To get information on the Head and Neck Cancer market value (US$ Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Head and Neck Cancer market industry

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Head and Neck Cancer Market Key Players Analysis - Advaxis, Inc. (US), Amgen, Inc. (US), AstraZeneca plc (UK), Boehringer Ingelheim GmbH (Germany). here

News-ID: 3889745 • Views:

More Releases from Insightace Analytic Pvt Ltd.

Ambulatory Surgical Center Software Market is on an Upward Growth Curve
Ambulatory Surgical Center Software Market is on an Upward Growth Curve
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Ambulatory Surgical Center Software Market- (By Software & Services (Software, Services), By Deployment Mode (Cloud-based Solutions, On-premise Solutions), By ASC Ownership (Physician-owned, Hospital-owned, Others), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Ambulatory Surgical Center Software Market is is expected to show a CAGR of
Laryngeal Stents Market Report- Expansive Coverage on the Profit Sources
Laryngeal Stents Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Laryngeal Stents Market- (By Type (Hood Laryngeal Stent and Tubular Laryngeal Stent), By Application (Child and Adult)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Laryngeal Stents Market Size is valued at USD 45.67 Mn in 2023 and is predicted to reach USD 67.53 Mn
Intelligent Prosthetics Market Future Trends and Scope Analysis Report
Intelligent Prosthetics Market Future Trends and Scope Analysis Report
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intelligent Prosthetics Market Size, Share & Trends Analysis Report By Product (Upper Extremity, Lower Extremity), By Distribution Channel (Hospitals, Prosthetic Clinics, Rehabilitation Centre, Others)- Market Outlook And Industry Analysis 2031" The Global Intelligent Prosthetics Market is valued at US$ 835.5 Mn in 2023, and it is expected to reach US$ 1,233.7 Mn by 2031, with a
Immunoturbidimetry Reagents Market Report on the Untapped Growth Opportunities in the Industry
Immunoturbidimetry Reagents Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Immunoturbidimetry Reagents Market- (By Type (Common Immune Turbidimetric Reagent, Latex Enhanced Immune Turbidimetric Reagent), By Application (Glycated hemoglobin, Retinol Binding Protein, C-Reactive Protein, Anti-streptococcal hemolysin "O", Rheumatoid Factor, Other)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the latest research by InsightAce Analytic, the Global Immunoturbidimetry Reagents Market is expected to witness a

All 5 Releases


More Releases for Head

Green Dot Sign® Going Head-to-Head with Traditional Plastic ADA Signs
After the success of their groundbreaking sustainable ADA compliant interior signs, Green Dot Sign® is now offering a more affordable and adaptable option than ever before: Low profile office signs. Nussbaum started considering environmentally-friendly manufacturing methods and products while working at his prior sign company. The idea to create signage from a wood base and non-toxic 3D printed material for lettering, braille, and pictograms was sparked by a braille sign with
China and India are growing head to head in Companion Diagnostic market
“Asia-Pacific Companion Diagnostics Market" research report, published by Market Data Forecast estimates that the market is growing with a CAGR of 27.91% to reach USD 2.17 billion by 2021, from USD 0.63 billion in 2016, which amounts to a cumulative growth of USD 1.54 billion. A companion diagnostics device is a medical device that provides information which is necessary for drug safety and effectives or any other biological product. This helps
East and West going head to head in Asia-Pacific Food Emulsifiers Market
Asia-Pacific Food Emulsifiers Market" research report, published by Market Data Forecast delineates that the market is growing with a CAGR of 6.15% to reach USD 0.78 billion by 2021, from USD 0.58 billion in 2016, which amounts to a cumulative growth of USD 0.20 billion. View Full Report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/ Download Free Sample report at http://www.marketdataforecast.com/market-reports/asia-pacific-food-emulsifiers-market-564/request-sample A substance used in food manufacturing which helps to combine liquids of different thicknesses is known as
dinCloud Earns Top Marks in Head-to-Head Comparison
The #1 Brand in Hosted Virtual Desktops LOS ANGELES, CA – June 19, 2012 – dinCloud, a cloud transformation company and provider of hosted virtual desktops, has come out on top as the leading provider of DaaS (Desktop as a Service) in a head-to-head comparison of five market leaders by ExtremeLabs. dinCloud’s solution received the groupings highest marks for the solution’s good control, as well as fast response, and was the
University Students go head to head in University of Bolton’s “Sports Fiesta …
The University of Bolton Student’s Council and the Student Activities Department organized an integrated program of sporting activities around the theme "Sports Fiesta 2012" which drew a number of Universities from the Northern Emirates and Dubai. The activities took place at UOB RAK Campus. Separate activities for male and female attendees included; badminton, basketball, chess, cricket, darts, tug-o-war, sprint race, football and volleyball matches, and other recreational games. To coincide with the
KnowledgetoAction Departments Go Head to Head in a Bowling Competition
London, UK ( ) October 25, 2010 - Employees of KnowledgetoAction (http://knowledgeandaction.co.uk) have been going head to head against each other in a series of team building competitions that began on September 1, 2010. Knowledge to Action believes strongly in team building and this event showcased their desire for excellent team cooperation and communication between departments, allowing for more cohesiveness within Knowledge to Action. Most recently, each of the KnowledgetoAction